EcoR1 Capital, LLC - May 26, 2023 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
10%+ Owner
Signature
Oleg Nodelman
Stock symbol
TCRX
Transactions as of
May 26, 2023
Transactions value $
$0
Form type
3
Date filed
6/5/2023, 04:09 PM
Previous filing
Mar 30, 2023
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRX Voting Common Stock 5M May 26, 2023 See Notes 1 and 2 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such ecurities except to the extent of their respective pecuniary interests therein.
F2 Qualified Fund directly holds 4,640,415 of the shares of Voting Common Stock reported in this Form 3.